Invention Grant
- Patent Title: Human rhinovirus (HRV) antibodies
- Patent Title (中): 人类鼻病毒（HRV）抗体
-
Application No.: US13596463Application Date: 2012-08-28
-
Publication No.: US08822651B2Publication Date: 2014-09-02
- Inventor: Po-Ying Chan-Hui
- Applicant: Po-Ying Chan-Hui
- Applicant Address: US WA Seattle
- Assignee: Theraclone Sciences, Inc.
- Current Assignee: Theraclone Sciences, Inc.
- Current Assignee Address: US WA Seattle
- Main IPC: C07K16/00
- IPC: C07K16/00
Abstract:
The invention provides isolated fully human monoclonal anti-HRV antibodies, as well as method of making and using these antibodies. Anti-HRV antibodies of the invention prevent or treat subjects having HRV-infections, and related diseases, including, but not limited to, the common cold, nasopharyngitis, croup, pneumonia, bronchiolitis, asthma, chronic obstructive pulmonary disease (COPD), sinusitis, bacterial superinfection, and cystic fibrosis.
Public/Granted literature
- US20130052163A1 Human Rhinovirus (HRV) Antibodies Public/Granted day:2013-02-28
Information query
